Price$25.05-0.20 (-0.79%)
01:30 PM07:45 PM
News · 26 weeks580%
2025-12-142026-06-07
Mix5690d
- Insider23(41%)
- Analyst11(20%)
- SEC Filings7(13%)
- Other8(14%)
- Offering6(11%)
- Earnings1(2%)
Latest news
25 items- SECJanus Living Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Janus Living, Inc. (0002100805) (Filer)
- SECSEC Form 424B4 filed by Janus Living Inc.424B4 - Janus Living, Inc. (0002100805) (Filer)
- SECSEC Form EFFECT filed by Janus Living Inc.EFFECT - Janus Living, Inc. (0002100805) (Filer)
- PRJanus Living Announces Pricing of Public Offering of Class A-1 Common StockJanus Living, Inc. (NYSE:JAN) ("Janus Living"), a pure-play senior housing real estate investment trust (REIT), announced today the pricing of its public offering of 25,000,000 shares of its Class A-1 common stock at a price to the public of $25.00 per share. In addition, Janus Living has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its Class A-1 common stock at the public offering price, less the underwriting discount. The offering is expected to close on June 4, 2026, subject to customary closing conditions. Janus Living expects to use the net proceeds received from the offering to pursue acquisition and investment opportunities that meet
- PRJanus Living Announces Launch of Public Offering of Class A-1 Common StockJanus Living, Inc. (NYSE:JAN) ("Janus Living"), a pure-play senior housing real estate investment trust (REIT), announced today the launch of its public offering of 25,000,000 shares of its Class A-1 common stock pursuant to a registration statement on Form S-11 filed with the Securities and Exchange Commission (the "SEC"). Janus Living expects to grant the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its Class A-1 common stock. Janus Living expects to use the net proceeds received from the proposed offering to pursue acquisition and investment opportunities that meet its investment criteria and for general corporate purposes. BofA Securities, J.P. Mo
- SECSEC Form S-11 filed by Janus Living Inc.S-11 - Janus Living, Inc. (0002100805) (Filer)
- SECSEC Form SCHEDULE 13G filed by Janus Living Inc.SCHEDULE 13G - Janus Living, Inc. (0002100805) (Subject)
- PRJanus Living Declares Common Stock Cash Dividends for the First and Second Quarters of 2026Janus Living, Inc. (NYSE:JAN), a pure-play senior housing real estate investment trust (REIT), announced its Board of Directors today declared a pro rata quarterly common stock cash dividend of $0.0174 per share for the first quarter of 2026 and a quarterly common stock cash dividend of $0.1425 per share for the second quarter of 2026, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The quarterly dividend reflects an annualized dividend amount of $0.57 per share of common stock. Record Date Payment Date Amount Friday, June 12, 2026 Wednesday, Jun
- SECSEC Form 10-Q filed by Janus Living Inc.10-Q - Janus Living, Inc. (0002100805) (Filer)
- SECJanus Living Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Janus Living, Inc. (0002100805) (Filer)
- PRJanus Living Reports First Quarter 2026 ResultsJanus Living, Inc. (NYSE:JAN), a pure-play senior housing real estate investment trust (REIT), announced results for the quarter ended March 31, 2026. FIRST QUARTER 2026 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS (all percentage changes compare first quarter 2026 to first quarter 2025 unless otherwise noted) Post-IPO net loss of $(0.05) per share and quarterly net income of $0.13 per share Consolidated revenues of $200 million increased 35% and Adjusted EBITDAre of $65 million increased 42% FFO as Adjusted of $0.23 per share increased 35% Same-store adjusted NOI increased 13.8% and margin expanded 150 basis points ("bps") Same-store revenues increased 7.6% driven by 230 bps
- PRHealthpeak Properties Raises 2026 Earnings Guidance Following Completion of the Janus Living IPO, Accretive Capital Allocation, and Strong First Quarter 2026 ResultsHealthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the quarter ended March 31, 2026. FIRST QUARTER 2026 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.28 per share, Nareit FFO of $0.42 per share, and FFO as Adjusted of $0.45 per share In March 2026, Janus Living, Inc. (NYSE:JAN) ("Janus Living") completed its initial public offering ("IPO") at the high-end of the valuation range, generating approximately $880 million of net proceeds in an oversubscribed and upsized offering, to pursue accretive acquisition and investment opportunities As Janus Living's larg
- ANALYSTScotiabank initiated coverage on Janus Living with a new price targetScotiabank initiated coverage of Janus Living with a rating of Sector Outperform and set a new price target of $28.00
- ANALYSTKeyBanc Capital Markets initiated coverage on Janus Living with a new price targetKeyBanc Capital Markets initiated coverage of Janus Living with a rating of Overweight and set a new price target of $28.00
- ANALYSTBarclays initiated coverage on Janus Living with a new price targetBarclays initiated coverage of Janus Living with a rating of Overweight and set a new price target of $26.00
- ANALYSTMorgan Stanley initiated coverage on Janus Living with a new price targetMorgan Stanley initiated coverage of Janus Living with a rating of Overweight and set a new price target of $28.00
- ANALYSTAnalyst initiated coverage on Janus Living with a new price targetAnalyst initiated coverage of Janus Living with a rating of Overweight and set a new price target of $26.00
- ANALYSTRBC Capital Mkts initiated coverage on Janus Living with a new price targetRBC Capital Mkts initiated coverage of Janus Living with a rating of Outperform and set a new price target of $27.00
- ANALYSTWells Fargo initiated coverage on Janus Living with a new price targetWells Fargo initiated coverage of Janus Living with a rating of Overweight and set a new price target of $27.00
- ANALYSTBofA Securities initiated coverage on Janus Living with a new price targetBofA Securities initiated coverage of Janus Living with a rating of Buy and set a new price target of $29.00
- ANALYSTBNP Paribas Exane initiated coverage on Janus Living with a new price targetBNP Paribas Exane initiated coverage of Janus Living with a rating of Outperform and set a new price target of $27.00
- ANALYSTGoldman initiated coverage on Janus Living with a new price targetGoldman initiated coverage of Janus Living with a rating of Neutral and set a new price target of $27.00
- ANALYSTCantor Fitzgerald initiated coverage on Janus Living with a new price targetCantor Fitzgerald initiated coverage of Janus Living with a rating of Overweight and set a new price target of $27.00
- PRJanus Living Announces Dates of First Quarter 2026 Earnings Release, Conference Call, and WebcastJanus Living, Inc. (NYSE:JAN), a pure-play senior housing real estate investment trust (REIT), is scheduled to report first quarter 2026 financial results after the close of trading on the New York Stock Exchange on Tuesday, May 5, 2026. Janus Living will host a conference call and webcast on Wednesday, May 6, 2026 at 12:00 p.m. Eastern Time to review its financial performance and operating results. The conference call can be accessed in the following ways: Janus Living's website: https://ir.janusreit.com/events-and-presentations Webcast: https://events.q4inc.com/attendee/263858499. Joining via webcast is recommended for those who will not be asking questions. Telephone: The pa
- INSIDERSEC Form 4 filed by Sandstrom Katherine M4 - Janus Living, Inc. (0002100805) (Issuer)
JAN FAQ
8 questionsWhat does Janus Living Inc. do?
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain. It operates in three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides...Where does JAN stock trade?
Janus Living Inc. (JAN) is listed on NASDAQ.What sector and industry is JAN in?
Janus Living Inc. operates in the Real Estate sector, Real Estate Investment Trusts industry.When did Janus Living Inc. go public?
Janus Living Inc. (JAN) completed its IPO in 2026.Does JAN pay a dividend?
Yes. JAN's next ex-dividend date is 2026-06-12 with a declared cash dividend of $0.16 per share, payable 2026-06-24.What are analysts saying about JAN?
Janus Living Inc. has had 8 recent analyst actions on file. The most recent action was from Scotiabank: Sector Outperform with a $2800.00 price target on 2026-04-14. Recent price targets range from $2600.00 to $2900.00.What companies are similar to JAN?
Notable peers in the same industry include WELL (Welltower Inc.), PLD (Prologis Inc.), EQIX (Equinix Inc.), AMT (American Tower Corporation (REIT)), SPG (Simon Property Group Inc.). Compare JAN side-by-side with any of them on Quantisnow.How can I track JAN on Quantisnow?
Quantisnow aggregates Janus Living Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow JAN to receive live email and push alerts on every new disclosure.